Why are anti counterfeit measures crucial in pharmaceutical packaging artwork?

Counterfeit medicines are those that are deliberately and fraudulently mislabeled with respect to identity and/or source. Counterfeiting can apply to both branded and generic products. Counterfeit medicines may include products with the wrong ingredients, without active ingredients, with insufficient active ingredients, or with fake packaging.

Up to one million people die annually from counterfeit pharmaceuticals. Since counterfeits can result in treatment failure or even death, it is essential for pharmaceutical companies to take immediate action to protect patients from irreparable damage.

1. Blockbuster ‘lifestyle’ medicines ​​along with an increase in the self-prescribing culture has created a demand for illicit use.
2. High-value rare disease medicines, rapid growth of worldwide sales of orphan drugs, which are increasing at a faster rate than sales of non-orphans.
3. Globalisation of markets, which has made distribution of counterfeit medicines easier.
4. Easy access and availability of technology to produce everything from labels to APIs.
5. Weak regulations ​​in many countries, in terms of enforcement and penalties governing the medicine distribution systems, which do not provide a strong enough deterrent.
6. The fact that counterfeiting is more profitable with lower risks than other drug related crimes has made it more attractive to organised crime.

At Vakils we help overcome counterfeiting and security issues by introducing anti counterfeiting measures in the artwork design. Some of these include.